EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • June 2nd, 2023 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 2nd, 2023 Company Industry JurisdictionThis equity purchase agreement is entered into as of June 1, 2023 (this “Agreement”), by and between AXIM Biotechnologies, Inc., a Nevada corporation (the “Company”), and Cross & Company, a Nevada corporation (the “Investor”).